Clinical Chemistry Specimen Collection PDF

Summary

This document provides an overview of specimen collection methods in clinical chemistry, covering skin puncture, arterial puncture, and venipuncture techniques. It also details considerations for selecting appropriate puncture sites.

Full Transcript

‭CLINICAL CHEMISTRY‬ ‭SPECIMEN COLLECTION & OTHER‬ ‭PRE-ANALYTICAL VARIABLES‬ ‭BY: DR. CATHERINE CABABA‬ ‭General Methods of Blood Collection‬ ‭‬ ‭SKIN PUNCTURE & HEEL STIC...

‭CLINICAL CHEMISTRY‬ ‭SPECIMEN COLLECTION & OTHER‬ ‭PRE-ANALYTICAL VARIABLES‬ ‭BY: DR. CATHERINE CABABA‬ ‭General Methods of Blood Collection‬ ‭‬ ‭SKIN PUNCTURE & HEEL STICK‬ ‭‬ ‭ARTERIAL PUNCTURE‬ ‭‬ ‭VENIPUNCTURE‬ ‭ KIN PUNCTURE‬ S ‭Sites of Puncture:‬ ‭‬ ‭Earlobe‬ ‭‬ ‭Palmar surface of the fingers‬ ‭‬ ‭Plantar surface of the heel and big toe‬ ‭Indications:‬ ‭‬ ‭Pediatric infants‬ ‭‬ ‭Geriatric patients‬ ‭‬ ‭Adults w/ exterme obesity, thrombotic‬ ‭tendency and severe burns‬ ‭ emolysis may occur in skin puncture for the ff‬ H ‭reasons:‬ ‭‬ ‭Brachial artery at the antecubital fossa‬ ‭1. There is residual alcohol at the skin puncture site.‬ ‭2. Patients have increased red blood cell fragility and‬ ‭high packed cell volume (e.g., newborns and infants).‬ ‭‬ ‭Dorsalis pedis artery in the foot‬ ‭ARTERIAL PUNCTURE‬ ‭‬ ‭Act of obtaining blood from an artery‬ ‭‬ ‭More difficult toAct of obtaining blood from‬ ‭an artery‬ ‭‬ ‭More difficult to perform because of‬ ‭inherent arterial pressure, difficulty in‬ ‭stopping the bleeding afterwards, and‬ ‭undesirable development of hematoma‬ ‭Sites of puncture:‬ ‭‬ ‭Radial artery at the wrist‬ ‭‬ ‭Brachial artery in the elbow‬ ‭‬ ‭Femoral artery in the groin‬ ‭Arterial Puncture Sites:‬ ‭‬ ‭Femoral artery just below the inguinal‬ ‭ligament‬ ‭ ertain areas are to be avoided when choosing a‬ C ‭site:‬ ‭‬ ‭Extensive scars from burns and surgery - it‬ ‭is difficult to puncture the scar tissue and‬ ‭obtain a specimen.‬ ‭‬ ‭Upper extremity on the side of a previous‬ ‭mastectomy - test results may be affected‬ ‭because of lymphedema.‬ ‭‬ ‭Hematoma - may cause erroneous test‬ ‭results. If another site is not available,‬ ‭collect the specimen distal to the hematoma.‬ ‭‬ ‭Intravenous therapy (IV) / blood‬ ‭Venipuncture‬ ‭transfusions - fluid may dilute the specimen,‬ ‭‬ ‭Open System‬ ‭so collect from the opposite arm if possible.‬ ‭‬ ‭Closed System‬ ‭Otherwise, satisfactory samples may be‬ ‭drawn below the IV by following these‬ ‭procedures:‬ ‭○‬ ‭Turn off the IV for at least 2‬ ‭minutes before venipuncture.‬ ‭○‬ ‭Apply the tourniquet below the IV‬ ‭site. Select a vein other than the‬ ‭one with the IV.‬ ‭○‬ ‭Perform the venipuncture. Draw 5‬ ‭ml of blood and discard‬ ‭befor‬ ‭drawing the specimen tubes for‬ ‭testing.‬ ‭‬ ‭Lines - Drawing from an intravenous line‬ ‭may avoid a difficult venipuncture, but‬ ‭introduces problems. The line must be‬ ‭ ENIPUNCTURE‬ V ‭flushed first. When using a syringe inserted‬ ‭Most frequent site – antecubital fossa:‬ ‭into the line, blood must be withdrawn‬ ‭‬ ‭Cephalic vein – on the upper forearm and on‬ ‭slowly to avoid hemolysis.‬ ‭the thumb side of the hand‬ ‭‬ ‭Edematous extremities - tissue fluid‬ ‭‬ ‭Basilic vein – on the lower forearm and on‬ ‭accumulation alters test results.‬ ‭the little finger side of the hand‬ ‭‬ ‭Median cubital vein‬ ‭Steps in Venipuncture:‬ ‭1.‬ ‭Carefully look over requisition slips. Note‬ ‭any special instructions.‬ ‭2.‬ ‭Identify the patient. Always ask the patient‬ ‭to state his/her full name.‬ ‭3.‬ ‭Verify diet restrictions. Fasting or‬ ‭non-fasting specimen? Note any medication‬ ‭that may interfere with testing.‬ ‭4.‬ ‭Assemble equipment‬ ‭5.‬ ‭Reassure and position the patient. Never tell‬ ‭the patient it will not hurt. The patient‬ ‭should be seated in a blood-drawing chair or‬ ‭lying down.‬ ‭6.‬ ‭Apply torniquet. Applied 3-4” above the‬ ‭Other Sites:‬ ‭intended site and should not be left in place‬ ‭for longer than 1 minute.‬ ‭7.‬ ‭Select venipuncture site. Have the patient‬ ‭make fist, to make the vein more prominent.‬ ‭Feel the vein.‬ ‭8.‬ ‭Cleanse the site w/ 70% alcohol, in a‬ ‭circular motion‬ ‭9.‬ ‭Uncover the needle and inspect for‬ ‭imperfections.‬ ‭10.‬ ‭Perform the venipuncture.‬ ‭11.‬ ‭Fill tubes: order of draw.(for evacuated‬ ‭system)‬ ‭12.‬ ‭Release tourniquet.‬ ‭13.‬ ‭Withdrawal and needle disposal.‬ ‭14.‬ ‭Label tubes.‬ t‭ubes will be necessary BEFORE you begin‬ ‭to draw blood, and determine the order of‬ ‭draw for the tubes.‬ ‭Releasing the tourniquet‬ ‭‬ ‭When the final tube is being drawn, release‬ ‭the tourniquet. Then remove the tube, and‬ ‭remove the needle.‬ ‭Applying pressure over the vein‬ ‭‬ ‭After the needle is removed from the vein,‬ ‭apply firm pressure over the site to achieve‬ ‭hemostasis.‬ ‭Applying bandage‬ ‭‬ ‭Apply a bandage to the area.‬ ‭Disposing needle into sharps‬ ‭‬ ‭Dispose of the needle into a sharps‬ ‭Patient identification‬ ‭container that is close by.‬ ‭‬ ‭The first step is always to identify the‬ ‭patient. Outpatient phlebotomy, as shown‬ ‭Labeling the specimens‬ ‭here, should take place with the patient‬ ‭‬ ‭Label the tubes, checking the requisition for‬ ‭seated.‬ ‭the proper identification.‬ ‭Equipment‬ ‭‬ ‭Here is the equipment for performing‬ ‭phlebotomy. Barrier protection for the‬ ‭Order of Draw‬ ‭phlebotomist consists of the latex gloves.‬ ‭‬ ‭Recommended when drawing multiple‬ ‭specimens from a single venipuncture‬ ‭Apply tourniquet and palpate for vein‬ ‭‬ ‭Purpose : to avoid possible test result error‬ ‭‬ ‭The tourniquet is applied and the‬ ‭due to cross contamination of tube additives‬ ‭phlebotomist palpates for a suitable vein for‬ ‭drawing blood.‬ ‭Sterilize the site‬ ‭‬ ‭The area of skin is cleaned with a‬ ‭disinfectant, here an alcohol swab.‬ ‭Insert needle‬ ‭‬ ‭The vein is anchored and the needle is‬ ‭inserted.‬ ‭Drawing the specimen‬ ‭‬ ‭The vacutainer tube is depressed into the‬ ‭needle to begin drawing blood.‬ ‭‬ ‭Additional vacutainer tubes can be utilized.‬ ‭Determine what tests are ordered and what‬ ‭Collection Tube Colors & Additives‬ ‭Complications in Blood Collection‬ ‭CLINICAL CHEMISTRY‬ ‭CARBOHYDRATES‬ ‭BY: DR. CATHERINE CABABA‬ ‭Overview of Carbohydrate Metabolism‬ ‭‬ ‭Carbohydrates are called carbohydrates‬ ‭because they are essentially hydrates of‬ ‭carbon (i.e. they are composed of carbon‬ ‭and water and have a composition of‬ ‭(CH2O)n.‬ ‭‬ ‭The major nutritional role of carbohydrates‬ ‭is to provide energy and digestible‬ ‭carbohydrates provide 4 kilocalories per‬ ‭gram. No single carbohydrate is essential,‬ ‭but carbohydrates do participate in many‬ ‭required functions in the body.‬ ‭Glucose‬ ‭‬ ‭Comes from food.‬ ‭○‬ ‭Carbohydrates are the main dietary‬ ‭source of glucose.‬ ‭‬ ‭Glucose levels‬ ‭Disaccharides‬ ‭○‬ ‭rise after meals for an hour or two‬ ‭by a few grams‬ ‭○‬ ‭usually lowest in the morning,‬ ‭before the first meal of the day.‬ ‭‬ ‭Transported via the bloodstream‬ ‭Complex carbohydrates‬ ‭○‬ ‭from the intestines or liver to body‬ ‭‬ ‭Oligosaccharides‬ ‭cells,‬ ‭‬ ‭Polysaccharides‬ ‭○‬ ‭Starch‬ ‭‬ G ‭ lucose is the primary source of energy for‬ ‭○‬ ‭Glycogen‬ ‭the body's cells‬ ‭○‬ ‭Dietary fiber‬ ‭○‬ ‭fats and oils being primarily a‬ ‭Starch‬ ‭compact energy store.‬ ‭‬ F ‭ ailure to maintain blood glucose in the‬ ‭normal range leads to conditions of‬ ‭persistently high (Hyperglycemia) or low‬ ‭(Hypoglycemia) blood sugar.‬ 1‭ 20 grams of glucose / day =‬ ‭480 calories‬ ‭Simple Sugars -‬ ‭‬ ‭Major storage carbohydrate in higher plants‬ ‭‬ A ‭ mylose – long straight glucose chains‬ ‭‬ ‭Adipose and liver‬ ‭(a1-4)‬ ‭○‬ ‭Glucose acetyl CoA‬ ‭‬ ‭Amylopectin – branched every 24-30 glc‬ ‭○‬ ‭Glucose to glycerol for triglyceride‬ ‭residues (a 1-6)‬ ‭synthesis‬ ‭‬ ‭Provides 80% of dietary calories in humans‬ ‭○‬ ‭Liver releases glucose for other‬ ‭worldwide‬ ‭tissues‬ ‭‬ ‭Nervous system‬ ‭Glycogen‬ ‭○‬ ‭Always use glucose except during‬ ‭extreme fasts‬ ‭‬ ‭Reproductive tract/mammary‬ ‭○‬ ‭Glucose required by fetus‬ ‭○‬ ‭Lactose major milk carbohydrate‬ ‭‬ ‭Red blood cells‬ ‭○‬ ‭No mitochondria‬ ‭○‬ ‭Oxidize glucose to lactate‬ ‭○‬ ‭Lactate returned to liver for‬ ‭Gluconeogenesis‬ ‭Regulation of Carbohydrate Metabolism‬ ‭‬ ‭ ajor storage carbohydrate in animals‬ M ‭‬ ‭Insulin‬ ‭‬ ‭Long straight glucose chains (a1-4)‬ ‭‬ ‭Glucagon‬ ‭‬ ‭Branched every 4-8 glc residues (a 1-6)‬ ‭‬ ‭Epinephrine‬ ‭‬ ‭More branched than starch‬ ‭‬ ‭Cortisol‬ ‭‬ ‭Less osmotic pressure‬ ‭‬ ‭Growth Hormone‬ ‭‬ ‭Easily mobilized‬ ‭‬ ‭Thyroxine‬ ‭‬ ‭Somatostatin‬ ‭Carbohydrate Metabolism‬ ‭‬ ‭Glycogenesis‬ ‭Beta Cells‬ ‭‬ ‭Glycogenolysis‬ ‭‬ ‭Beta cells form the Islets of Langerhans in‬ ‭‬ ‭Glycolysis (Embden-Meyerhoff Pathway)‬ ‭the pancreas‬ ‭‬ ‭Gluconeogenesis‬ ‭‬ ‭Insulin is produced only by beta cells in the‬ ‭pancreas‬ ‭Carbohydrates‬ ‭‬ ‭Glucagon also produced in the pancreas‬ ‭‬ ‭Serve as primary source of energy in the cell‬ ‭(acts to increase blood glucose levels when‬ ‭‬ ‭Central to all metabolic processes‬ ‭they are below normal)‬ ‭Secretion of Insulin‬ ‭‬ ‭Primarily in response to increase blood‬ ‭glucose levels‬ ‭‬ ‭Secondarily‬ ‭○‬ ‭Neural stimuli‬ ‭○‬ ‭Taste, smell of food‬ ‭○‬ ‭Increased amino acids in blood‬ ‭○‬ ‭Increased fatty acids in blood‬ ‭Normal Release of Insulin‬ ‭‬ ‭Normal fasting blood glucose ranges from‬ ‭ arbohydrate Metabolism/ Utilization- Tissue‬ C ‭80-90 mg per 100 ml‬ ‭Specificity‬ ‭‬ ‭Stored insulin released first‬ ‭‬ ‭Muscle – cardiac and skeletal‬ ‭‬ ‭Synthesis of more insulin triggered‬ ‭○‬ ‭Oxidize glucose/produce and store‬ ‭glycogen‬ ‭○‬ ‭Breakdown glycogen (fasted state)‬ ‭○‬ ‭Shift to other fuels in fasting state‬ ‭(fatty acids)‬ ‭‬ C ‭ SF glucose conc is approximately 60% of‬ ‭plasma glucose conc.‬ ‭‬ ‭Urine glucose‬‭– renal threshold = 160-180‬ ‭mg/dl‬ ‭Glucose methods‬ ‭‬ ‭Glucose Oxidase‬ ‭Glucose + O‬‭2‬ ‭+ H‬‭2‬‭O --------------gluconic acid + H‬‭2‬‭O‬‭2‬ ‭ ‬‭2‬‭O‭2‬ ‬ ‭+ reduced chromogen-----------oxidized‬ H ‭chromogen + H‬‭2‬‭O‬ ‭Insulin affects many organs:‬ ‭ alse low results:‬ F ‭‬ ‭It stimulates skeletal muscle fibers.‬ ‭→‬‭Inc. uric acid‬ ‭‬ ‭It stimulates liver cells.‬ ‭→ Inc. bilirubin‬ ‭‬ ‭It acts on fat cells‬ ‭→ Inc. ascorbic acid‬ ‭‬ ‭It inhibits production of certain enzymes.‬ ‭‬ ‭In each case, insulin triggers thes effects by‬ ‭‬ ‭Hexokinase‬ ‭binding to the insulin receptor.‬ ‭Glucose + ATP --------------------- G-6-P + ADP‬ ‭ alse low results:‬ F ‭→‬‭Hemolysis‬ ‭→‬‭Inc. bilirubin‬ ‭Non Enzymatic Methods‬ ‭1.‬ ‭Nelson- Somogyi – Copper reduction mtd‬ ‭‬ ‭Measure of true glucose‬ ‭‬ ‭Uses BaSO4 to remove non glucose‬ ‭reducing subs (saccharoids)‬ ‭‬ ‭Reagent: arsenomolybdic acid‬ ‭‬ ‭Product: aresenomolybdenum blue‬ ‭‬ ‭Conc of glucose is proportional to the‬ ‭absorbance of the solution‬ ‭Glucose Regulation by Insulin‬ ‭‬ ‭Liver‬ ‭2.‬ H ‭ agedorn-Jensen – Ferric reduction mtd‬ ‭○‬ ‭Gluconeogenesis‬ ‭‬ ‭Inverse colorimetry‬ ‭○‬ ‭Glycogenolysis‬ ‭‬ ‭Reagent: Ferricyanide (yellow)‬ ‭‬ ‭Muscle & adipose tissue‬ ‭‬ ‭Product: Ferrocyanide ( colorless)‬ ‭○‬ ‭Increased rate of glucose uptake4‬ ‭‬ ‭Glucose conc. is proportional to the decrease‬ ‭‬ ‭Lipid metabolism‬ ‭in absorbance‬ ‭○‬ ‭Increased synthesis of lipids in‬ ‭liver and fat cells‬ ‭3.‬ O ‭ rtho-Toluidine‬ ‭○‬ ‭Attenuation of fatty acid release‬ ‭‬ ‭Condensation with aromatic amines‬ ‭from triglycerides stored in muscle‬ ‭‬ ‭Most specific among the non-enzymatic‬ ‭& fat tissue‬ ‭methods‬ ‭‬ ‭Reagent: O-toluidine in glacial acetic acid‬ ‭‬ ‭Product: Shiff’s base (green)‬ ‭ eference Range‬ R ‭Conventional :70-110 mg/dl‬ ‭Conversion factor: 0.055‬ ‭S.I : 3.9-6.1 mmol/L‬ ‭Genetic Defects in Carbohydrate Metabolism‬ ‭1.Von Gierke’s dse‬ ‭‬ ‭Congenital form of glycogen storage dse‬ ‭‬ ‭Hypoglycemia‬ ‭Glucose Measurement‬ ‭‬ ‭Deficiency of the ENZ G-6-Phosphatase‬ ‭‬ ‭Specimens‬‭: whole blood, serum, plasma,‬ ‭urine, CSF‬ ‭2. Galactosemia‬ ‭‬ ‭Whole blood glucose is lower by 15%‬ ‭‬ ‭Deficiency of galactose -1-phosphate uridyl‬ ‭compared with serum or plasma‬ ‭transferase‬ ‭‬ ‭Capillary blood sample is slightly higher‬ ‭compared with venous blood‬ ‭Disorder of Carbohydrate Metabolism‬ ‭ iabetes Mellitus‬ D ‭‬ ‭Hyperglycemia‬ ‭(problem with glucose metabolism)‬ ‭‬ ‭Hypoglycemia‬ ‭‬ ‭Major health problem US/worldwide‬ ‭‬ ‭DM‬ ‭‬ ‭3 Classical signs:‬ ‭○‬ ‭Polydipsia,‬ ‭○‬ ‭Polyphagia,‬ ‭○‬ ‭Polyuria‬ ‭DIABETES MELLITUS‬ ‭‬ ‭Complications [lousy blood vessels]‬ ‭ isorders of Carbohydrate Metabolism‬ D ‭1. Nephropathy‬ ‭Hyperglycemia‬ ‭2. Neuropathy‬ ‭‬ ‭When blood glucose becomes high‬ ‭3. Retinopathy‬ ‭-‬ ‭INSULIN allows glucose to enter cells‬ ‭4. Atherosclerosis‬ ‭‬ ‭Liver‬ ‭-‬ ‭Production /storage of glycogen‬ -‭ ‬ ‭ lindness‬ B ‭-‬ ‭Inhibits glycogen breakdown‬ ‭-‬ ‭Renal failure‬ ‭-‬ ‭Increased protein & fat synthesis‬ ‭-‬ ‭Amputations‬ ‭(VLDL formation)‬ ‭-‬ ‭[heart attacks and strokes]‬ ‭‬ ‭Muscles‬ ‭-‬ ‭[OB/neonatal complications]‬ ‭-‬ ‭Promotes protein and glycogen‬ ‭synthesis‬ ‭ he good news:‬‭Blood glucose control reduces‬ T ‭‬ ‭Fat cells‬ ‭complications of Diabetes!‬ ‭-‬ ‭Promotes storage of triglycerides‬ ‭‬ ‭Drowsy‬ ‭ iabetes Mellitus :‬ D ‭‬ ‭Thirsty‬ ‭→‬‭a group of diseases characterized by high levels‬‭of‬ ‭blood glucose resulting from defects in insulin‬ ‭ ypoglycemia‬ H ‭production, insulin action, or both‬ ‭Diagnosed based on Whipple’s triad:‬ ‭‬ ‭20.8 million in US ( 7% of population)‬ ‭‬ ‭Low blood glucose‬ ‭‬ ‭estimated 14.6 million diagnosed (only 2/3)‬ ‭‬ ‭Accompanied by typical symptoms‬ ‭‬ ‭Consists of 3 types:‬ ‭‬ ‭Resolved by glucose administration‬ ‭1) Type 1 diabetes‬ ‭‬ ‭Weak, sweat‬ ‭2) Type 2 diabetes‬ ‭‬ ‭Confused/irritable/ disoriented‬ ‭3) Gestational diabetes‬ ‭‬ ‭Decreased plasma glucose levels‬ ‭‬ ‭Can be transient & relatively insignificant or‬ ‭Complications :‬ ‭life-threatening‬ ‭- Stroke‬ ‭‬ ‭Occurs in healthy-appearing and sick‬ ‭- Heart attack‬ ‭patients, as a result of reaction to medication‬ ‭- Kidney disease‬ ‭or of illness‬ ‭- Eye Disease‬ ‭‬ ‭Symptoms appear at a glucose level of about‬ ‭- Nerve Damage‬ ‭50–55 mg/dL.‬ ‭‬ ‭Symptoms:‬‭increased hunger, sweating,‬ ‭‬ ‭ ajor risk factors‬ M ‭nausea & vomiting, dizziness, nervousness‬ ‭-‬ ‭Family history‬ ‭& shaking, blurred speech & sight, mental‬ ‭-‬ ‭Obesity‬ ‭confusion‬ ‭-‬ ‭Origin (Afro-American, Hispanic, Native‬ ‭‬ ‭Glucagon: causes release of glucose from‬ ‭American, Asian-American)‬ ‭liver‬ -‭ ‬ ‭Age (older than 45)‬ ‭○‬ ‭“glycogenolysis (breakdown of‬ ‭-‬ ‭History of gestational diabetes‬ ‭glycogen to glucose)‬ ‭-‬ ‭High cholesterol‬ ‭○‬ ‭“glyconeogenesis of glucose not‬ ‭-‬ ‭Hypertension‬ ‭available‬ ‭‬ ‭Lipolysis (breakdown of‬ ‭fat)‬ ‭‬ ‭Proteolysis (breakdown of‬ ‭amino acids)‬ ‭Glucose Tolerance Test‬ ‭‬ ‭Confirmatory test for DM‬ ‭‬ ‭Patient’s response to a glucose load is tested‬ ‭by measuring blood glucose at specific time‬ ‭intervals‬ ‭Types of GTT‬ ‭A.‬ ‭OGTT‬ ‭Patient Preparation:‬ ‭‬ ‭Normal to high carbohydrate intake for 3‬ ‭days before the test‬ ‭‬ ‭Fasting for at least 10 hours‬ ‭‬ ‭Avoid medications like salicylates, diuretics,‬ ‭anti-convulsants, oral contraceptives, and‬ ‭corticosteroids 3 days prior to test‬ ‭‬ ‭Glucose load:‬ ‭50 grms – children‬ ‭75 grms – adults‬ ‭100 grms- pregnant women‬ ‭Procedure:‬ ‭‬ ‭Determine FBS‬ ‭‬ ‭Administer glucose load‬ ‭‬ ‭Determine blood glucose after 30 min, 1‬ ‭Who needs insulin medicine?‬ ‭hour, 2 hour and 3 hours‬ ‭‬ ‭Type I (insulin dependent) diabetes patients‬ ‭whose body produces no insulin.‬ ‭.‬ I‭ VGTT‬ B ‭‬ ‭Type 2 diabetes patients that do not always‬ ‭‬ ‭25g/dl glucose solution administered‬ ‭produce enough insulin.‬ ‭intravenously within 1-2 minutes‬ ‭Treatment‬ ‭‬ ‭Blood drawn before infusion and at‬ ‭‬ ‭subcutaneous injection‬ ‭1,3,5,10,20,30,40,60 and 120 minutes‬ ‭Criteria for the Diagnosis of Diabetes Mellitus‬ ‭following the end of infusion‬ ‭‬ ‭Three methods of diagnosis (each must be‬ ‭confirmed by one of the others on a‬ ‭Fructosamine‬ ‭subsequent day)‬ ‭‬ ‭Index for long term plasma glucose control‬ ‭1.‬ ‭Diabetes symptoms + random glucose‬ ‭(2-3 week period), indicating compliance‬ ‭level of ≥200 mg/dL‬ ‭and efficacy of DM therapy‬ ‭2.‬ ‭A fasting plasma glucose of ≥126 mg/dL‬ ‭3.‬ ‭An oral glucose tolerance test (OGTT)‬ ‭Glycated hemoglobin (HbA1c)‬ ‭w/ 2-hour postload (75-g glucose level)‬ ‭‬ ‭Index for long term plasma glucose control‬ ‭≥200 mg/dL‬ ‭(2-3month period), indicating compliance‬ ‭and efficacy of DM therapy‬ ‭‬ P‭ atients with following criteria have‬ ‭‬ ‭Specimen: EDTA whole blood sample‬ ‭“pre-diabetes”:‬ ‭‬ ‭Glycosylated Hemoglobin/Hemoglobin A1c‬ ‭Fasting glucose of ≥100 mg/dL but 200 mg/dl signals diabetes‬ ‭‬ ‭Ketones‬ ‭-‬ ‭Produced by liver through metabolism of‬ ‭A.K.A.: Glycated Hemoglobin tests A1C‬ ‭fatty acids‬ ‭-‬ ‭Provide a ready energy source from stored‬ *‭ **‬‭80 to 90 mg per 100 ml, is the normal fasting‬ ‭lipids‬ ‭blood glucose concentration in humans and most‬ ‭-‬ ‭Increase with carbohydrate deprivation or‬ ‭mammals which is associated with very low levels of‬ ‭decreased carbohydrate use (diabetes,‬ ‭insulin secretion.‬ ‭starvation/fasting, high-fat diets)‬ ‭-‬ ‭Three ketone bodies‬ ‭-‬ ‭Acetone (2%)‬ ‭-‬ ‭Acetoacetic acid (20%)‬ ‭-‬ ‭3-β-hydroxybutyric acid (78%)‬ ‭-‬ ‭ pecimen requirement is fresh serum or‬ S ‭urine.‬ ‭Diabetes Mellitus‬ ‭‬ ‭Prevention of effects: combination approach‬ ‭-‬ ‭Increased exercisE‬ ‭-‬ ‭Decreases need for insulin‬ ‭-‬ ‭Reduce calorie intake‬ ‭-‬ ‭Improves insulin sensitivity‬ ‭-‬ ‭Weight reduction‬ ‭-‬ ‭Improves insulin action‬ ‭Triad of Treatment‬ ‭‬ D ‭ iet‬ ‭‬ ‭Medication‬ ‭○‬ ‭Oral hypoglycemics‬ ‭○‬ ‭Insulins‬ ‭‬ ‭Exercise‬ ‭Some things to know…‬ ‭‬ D ‭ iabetic foot care‬ ‭-‬ ‭Dry, cracked skin + poor circulation could =‬ ‭loss of a limb‬ ‭-‬ ‭For the most part nurses don’t trim the nails‬ ‭of diabetic clients. Refer to Podiatrist.‬ ‭Typical diabetic foot ulcer‬ ‭CLINICAL CHEMISTRY‬ ‭PROTEIN‬ ‭BY: DR. CATHERINE CABABA‬ ‭General Characteristics‬ ‭-‬ ‭ ets proteins apart from pure carbohydrates‬ S ‭‬ ‭Molecular Size‬ ‭and lipids, which contain no nitrogen atoms‬ ‭-‬ ‭Macromolecule‬‭s – 6000 to several millions‬ ‭for some structural proteins‬ ‭‬ S ‭ ynthesis‬ ‭-‬ ‭Synthesized in the liver, except for the‬ ‭Structure‬ ‭immunoglobulins (plasma cells)‬ ‭-‬ ‭Continuous chain of carbon & nitrogen‬ ‭atoms joined together by peptide bonds‬ ‭‬ D ‭ istributions and Catabolism‬ ‭between adjacent amino acids‬ ‭-‬ ‭Distribution:‬‭extravascular, intravascular‬ ‭compartments‬ ‭Protein Structures‬ ‭-‬ ‭Catabolism:‬‭hydrolyzed to amino acids,‬ ‭‬ ‭Primary Structure‬‭– presents a linear‬ ‭deaminated producing ammonia & ketoacids‬ ‭sequence of amino acids‬ ‭-‬ ‭Ammonia‬‭converted to urea, excreted in the‬ ‭urine‬ ‭‬ S ‭ econdary Structure‬‭– twisted shape of‬ ‭-‬ ‭Keto Acids‬‭oxidized by means of Kreb’s‬ ‭primary structure due to rotation of bonds‬ ‭cycle – converted to glucose or fat‬ ‭‬ T ‭ ertiaryStructure‬‭– three-dimensional‬ ‭Nitrogen Balance‬ ‭structure that forms when the amino acid‬ ‭chain folds back on itself‬ ‭‬ N ‭ egative Nitrogen Balance‬ ‭-‬ ‭When protein catabolism exceeds protein‬ ‭‬ Q ‭ uaternary Structure‬‭– individual proteins‬ ‭anabolism‬ ‭or monomeric subunits that form more‬ ‭-‬ ‭Occurs in excessive tissue destruction such‬ ‭stable complexes as dimers, trimers, etc.‬ ‭as burns, wasting disease, continual high‬ ‭fevers or starvation‬ ‭‬ P ‭ ositive Nitrogen Balance‬ ‭-‬ ‭When anabolism is greater than catabolism‬ ‭-‬ ‭Occurs during growth, pregnancy, and repair‬ ‭processes‬ ‭Classification of Proteins‬ ‭As to Composition:‬ ‭‬ ‭Simple proteins‬ ‭-‬ ‭contain peptide chains which upon‬ ‭General Characteristics‬ ‭hydrolysis yield only amino acids‬ ‭-‬ ‭E.g. Albumin, globulin, albuminoids,‬ ‭‬ ‭Charge & Isoelectric Point‬ ‭histones, protamines‬ ‭-‬ p‭ H at which a particular protein has a net‬ ‭‬ C ‭ onjugated proteins‬ ‭charge equal to zero‬ ‭-‬ ‭Composed of protein(apoprotein) and a‬ ‭-‬ ‭At a pH below their pI, proteins carry a net‬ ‭non-protein moiety (prosthetic group)‬ ‭positive charge; above their pI they carry a‬ ‭-‬ ‭E.g.‬ ‭net negative charge‬ ‭-‬ ‭Chromoprotein –‬‭myoglobin,‬ ‭hemoglobin‬ ‭‬ ‭Double charge‬ ‭-‬ ‭Metalloprotein‬‭– ferritin,‬ ‭ceruloplasmin‬ -‭ ‬ ‭ mino group= positive‬ A ‭-‬ ‭Lipoprotein‬‭– HDL,LDL,VLDL‬ ‭-‬ ‭Carboxyl group = negative‬ ‭-‬ ‭Glycoprotein‬‭– haptoglobulin,‬ ‭orosomucoid‬ ‭ ‬ I‭ mmunogenicity‬ ‭-‬ ‭Nucleoprotein‬‭– RNA,DNA‬ ‭-‬ ‭Effective antigens because of their large‬ ‭As to Shape:‬ ‭molecular mass, content of tyrosine and‬ ‭‬ ‭Globular‬ ‭specificity by species‬ ‭-‬ ‭spherical in shape, with mobile & dynamic‬ ‭function‬ ‭‬ ‭Nitrogen Content‬ ‭-‬ ‭E.g. hormones, enzymes, hemoproteins‬ ‭‬ F ‭ ibrous‬ ‭.‬ F D ‭ ractionation by Electrophoresis‬ ‭-‬ ‭elongated in shape, for structural purposes‬ ‭‬ ‭With the use of barbital buffer (veronal) at‬ ‭-‬ ‭E.g. Keratin, collagen, elastin‬ ‭pH 8.6, all serum proteins become‬ ‭negatively charged and migrate towards the‬ ‭As to Solubility:‬ ‭anode and produce a pattern of separation on‬ ‭‬ ‭Albumin – soluble in water, insoluble in‬ ‭electrophoretogram‬ ‭organic solvents‬ ‭a.‬ ‭solid support media – agarose gel and‬ ‭‬ ‭Globulin – insoluble in water, soluble in‬ ‭cellulose acetate‬ ‭organic solvents‬ ‭b.‬ ‭After migration, stains may be used to locate‬ ‭‬ ‭Albuminoids – insoluble in most common‬ ‭and identify the separated fractions on the‬ ‭reagents‬ ‭sample, e.g. Ponceau S, Bromphenol blue,‬ ‭-‬ ‭E.g. Collagen, elastin, keratin, & other‬ ‭and Coomassie brilliant blue‬ ‭fibrous proteins‬ ‭c.‬ ‭Fractions are quantitated using a‬ ‭densitometer‬ ‭General Functions of Proteins‬ ‭d.‬ ‭Total proteins are separated as 5 distinct‬ ‭‬ ‭Tissue nutrition ( amino acids from proteins‬ ‭bands‬ ‭can be used for the production of energy by‬ ‭e.‬ ‭From fastest to slowest : albumin,‬ ‭means of the citric acid cycle)‬ ‭alpha-1-globulin, alpha-2-globulin,beta‬ ‭‬ ‭Distribution of water among the‬ ‭globulin,and gamma globulin‬ ‭compartments of the body‬ ‭‬ ‭As buffers, maintain pH‬ ‭‬ ‭As transport proteins‬ ‭‬ ‭Protect the body against infection through‬ ‭antibodies and the complement system‬ ‭‬ ‭Act as receptors for hormones‬ ‭‬ ‭As enzymes, hasten biological chemical‬ ‭reaction‬ ‭‬ ‭As clotting factors, aid in hemostasis‬ ‭‬ ‭Structural role‬ ‭e.g. Collagen – major fibrous element of‬ ‭skin, bone, tendon, cartilage, blood vessels, and teeth‬ ‭Pathologic Serum Protein Electrophoresis‬ ‭Laboratory tests of Proteins‬ ‭Patterns‬ ‭‬ ‭Hepatic Cirrhosis‬ ‭Total Protein Methods:‬ ‭-‬ ‭When liver function is sufficiently‬ ‭A.‬ ‭Kjeldahl‬ ‭diminished, protein synthesizing capacity is‬ ‭‬ ‭Acid digestion of protein w/ measurement of‬ ‭compromised and concentrations of albumin‬ ‭total nitrogen‬ ‭and proteins in the alpha and beta bands are‬ ‭‬ ‭Reference method‬ ‭decreased. An additional common finding is‬ ‭‬ ‭2-step reaction:‬ ‭beta-gamma bridging due to increased IgA.‬ ‭○‬ ‭Kjeldahlization – conversion of‬ ‭nitrogen to ammonia‬ ‭Nitrogen H2SO4 ammonia‬ ‭○‬ ‭ammonia measurement:‬ ‭1. Nessler’s rxn‬ ‭2. Berthelot rxn‬ ‭.‬ B B ‭ iuret‬ ‭‬ ‭Formation of violet-colored chelate between‬ ‭cupric ions and peptide bond‬ ‭‬ ‭Composition of biuret reagent:‬ ‭-‬ ‭Cupric ion – breaks the peptide bonds‬ ‭-‬ ‭Tartrate salt – keeps copper in solution‬ ‭-‬ ‭Potassium iodide – stabilized cupric ions‬ ‭(prevents reduction to cuprous ion‬ ‭.‬ R C ‭ efractometry‬ ‭‬ ‭Measurement of refractive index which‬ ‭reflects the concentration of proteins‬ ‭‬ ‭Rapid and simple‬ ‭‬ N ‭ ephrotic Syndrome --‬ ‭‬ A ‭ cute Inflammation‬ ‭-‬ ‭Renal disease involving the glomeruli is‬ ‭-‬ ‭Alpha-1 and alpha-2 bands are increased‬ ‭always associated with increased urinary‬ ‭during the inflammatory response from‬ ‭protein loss. When protein loss is greater‬ ‭increased hepatic synthesis of acute phase‬ ‭than 3-4 g/day, the protein synthesizing‬ ‭reactant proteins.‬ ‭capacity of the liver is exceeded and‬ ‭hypoproteinemia, accompanied by anasarca,‬ ‭develops to cause the nephrotic syndrome.‬ ‭The massive urine protein loss is due to‬ ‭increased permeability of glomeruli to‬ ‭protein. The permeability increase may be‬ ‭minimal so that only albumin and other‬ ‭smaller molecular weight proteins are‬ ‭selectively filtered (selective nephrosis, as in‬ ‭Minimal Change Disease) or may be greater‬ ‭so that larger proteins are also filtered‬ ‭(nonselective nephrosis, as in membranous‬ ‭glomerulonephritis) as is the case in the‬ ‭example shown. Alpha-2-macroglobulin is‬ ‭sufficiently large so that it is not filtered and‬ ‭increased synthesis (from the general‬ ‭hepatic protein synthesis) causes its‬ ‭accumulation.‬ ‭‬ C ‭ hronic Inflammation‬ ‭-‬ ‭Immunoglobulin synthesis by antigen‬ ‭activated B lymphocytes transformed to‬ ‭plasma cells is demonstrated by the‬ ‭increased polyclonal gamma band.‬ ‭‬ A ‭ lpha-1-Antitrypsin Deficiency --‬ ‭-‬ ‭A genetic defect causes a deficiency of‬ ‭alpha-1-antitrypsin. The antiprotease‬ ‭deficiency results in a propensity to develop‬ ‭emphysema. Since alpha-1-antitrypsin is the‬ ‭major component of the alpha-1 band,‬ ‭deficiency is suggested by a reduced alpha-1‬ ‭band‬ ‭ ‬ I‭ mmunoglobulin Deficiency --‬ ‭-‬ ‭Deficient immunoglobulin synthesis is‬ ‭revealed by a markedly diminished gamma‬ ‭band. Affected individuals are prone to‬ ‭recurrent infection.‬ ‭Alterations in Serum Total Proteins‬ ‭‬ ‭Hyperproteinemia:‬ ‭-‬ ‭Dehydration‬ ‭-‬ ‭Monoclonal or polyclonal gammopathies‬ ‭‬ H ‭ ypoproteinemia:‬ ‭‬ M ‭ onoclonal Gammopathy‬ ‭-‬ ‭Increased Protein loss – Nephrotic‬ ‭-‬ ‭An unusually sharp band in the gamma‬ ‭syndrome, blood loss, burns‬ ‭region strongly suggests the presence of a‬ ‭-‬ ‭Increased catabolism –‬ ‭homogeneous immunoglobulin and, thus,‬ ‭inflammation,pregnancy‬ ‭the malignant proliferation of plasma cells‬ ‭-‬ ‭Decreased synthesis –‬ ‭from a single cell (multiple myeloma) in‬ ‭liver disease,decreased amino acid intake‬ ‭contrast to the broad, heterogeneous, or‬ ‭polyclonal, gamma band as exhibited above‬ ‭Determination of Individual proteins‬ ‭in chronic inflammation from‬ ‭‬ ‭Albumin‬ ‭immunoglobulin synthesis by many different‬ ‭-‬ ‭protein present in highest concentration in‬ ‭clones of plasma cells.‬ ‭the serum‬ ‭-‬ ‭Homogeneous immunoglobulins are also‬ ‭-‬ ‭Produced by the liver‬ ‭found in Waldenstrom's macroglobulinemia‬ ‭-‬ ‭Functions: regulation of normal osmotic‬ ‭(where the sharp gamma band is always‬ ‭pressure; general transport protein‬ ‭IgM).‬ ‭Alterations in Serum Albumin‬ ‭‬ ‭Hyperalbuminemia:‬ ‭○‬ ‭Dehydration‬ ‭‬ ‭Hypoalbuminemia:‬ ‭○‬ ‭Increased albumin loss‬‭–‬ ‭Nephrotic syndrome, blood loss,‬ ‭burns‬ ‭○‬ ‭Increased albumin catabolism‬‭–‬ ‭inflammation,pregnancy‬ ‭○‬ ‭Decreased albumin synthesis‬‭–‬ ‭liver disease,decreased amino acid intake‬ ‭Globulin‬ ‭○‬ ‭Decreased in inflammation‬ ‭‬ ‭Total globulins are measured by subtracting‬ ‭albumin from the total protein concentration‬ ‭‬ ‭Bence Jones Protein‬ ‭○‬ ‭An abnormal protein in the urine of‬ ‭patients with multiple myeloma‬ ‭○‬ ‭Demonstrated by heat and acetic‬ ‭acid method: Bence Jones protein‬ ‭precipitates when solution is heated‬ ‭at 60-65 deg Celcius, becomes‬ ‭Conversion factor: 10‬ ‭soluble when heated at 100 deg‬ ‭Celcius and re-precipitates when‬ ‭Fibrinogen‬ ‭the solution cools to 60-65 deg‬ ‭‬ ‭Most abundant of the coagulation factors‬ ‭Celcius‬ ‭responsible for the formation of fibrin clot‬ ‭‬ ‭Found in plasma not in serum‬ ‭‬ ‭Cryoglobulins‬ ‭‬ ‭Methods of Determination:‬ ‭○‬ ‭Serum globulins that precipitate on‬ ‭A.‬ ‭Parfentjev mtd – fibrinogen is precipitated‬ ‭cooling and re-dissolve on warming‬ ‭w/ ammonium sulfate & sodium chloride‬ ‭from a citrated plasma. Dilution of the‬ ‭mixture is read spectrophotometrically‬ ‭B.‬ ‭Howe’s mtd – fibrinogen is precipitated w/‬ ‭calcium chloride and assayed using Kjeldahl‬ ‭mtd.‬ ‭Reference Value: 200-400 mg/dl ( 2.0-4.2 g/L)‬ ‭Miscellaneous proteins‬ ‭‬ ‭Alpha1-antitrypsin‬ ‭○‬ ‭acute phase reactant, makes up‬ ‭90% of alpha-1 region‬ ‭○‬ ‭Function: neutralize trypsin-like‬ ‭enzymes that can cause damage to‬ ‭structural proteins‬ ‭○‬ ‭Decrease may cause early onset of‬ ‭emphysema or infantile hepatitis‬ ‭‬ ‭Alpha1-fetoprotein‬ ‭○‬ ‭Principal fetal protein‬ ‭○‬ ‭No known adult function‬ ‭○‬ ‭Increased concentration in adult‬ ‭may indicate hepatocellular‬ ‭carcinoma‬ ‭‬ ‭Haptoglobulin‬ ‭○‬ ‭Binds and transports free‬ ‭hemoglobin‬ ‭○‬ ‭Decreased in intravascular‬ ‭hemolysis‬ ‭‬ ‭Ceruloplasmin‬ ‭○‬ ‭Copper transport protein‬ ‭○‬ ‭Decreased in Wilson’s disease‬ ‭○‬ ‭Increased in copper toxicity‬ ‭‬ ‭Alpha2-Macroglobulin‬ ‭○‬ ‭One of the largest protein in the‬ ‭plasma‬ ‭○‬ ‭Dramatic increase in nephrotic‬ ‭syndrome‬ ‭‬ ‭Transferrin‬ ‭○‬ ‭Transports iron‬ ‭○‬ ‭Increased in iron deficiency anemia‬ ‭CLINICAL CHEMISTRY‬ ‭LIPID PROFILE‬ ‭BY: DR. CATHERINE CABABA‬ ‭Lipid Panel; Coronary Risk Panel‬ ‭‬ S ‭ torage form of lipid in man‬ ‭‬ ‭Provides insulation to vital organs‬ ‭ elated Tests:‬‭Cholesterol Cholesterol; HDL-C‬ R ‭‬ ‭Transported in the blood by chylomicrons‬ ‭Cholesterol; HDL-C; LDL-C Cholesterol; HDL-C;‬ ‭and VLDL‬ ‭LDL-C; Triglycerides Cholesterol; HDL-C; LDL-C;‬ ‭‬ ‭Causes turbidity of serum after meals‬ ‭Triglycerides; VLDL-C Cholesterol; HDL-C;‬ ‭LDL-C; Triglycerides; VLDL-C; Cardiac Risk‬ ‭Sources:‬ ‭Assessment‬ ‭‬ ‭Exogenous‬ ‭‬ ‭Endogenous‬ ‭Lipid profile‬ ‭‬ ‭group of tests that are often ordered together‬ ‭Cholesterol‬ ‭to determine risk of coronary heart disease‬ ‭‬ ‭Steroid alcohol‬ ‭‬ ‭tests that have been shown to be good‬ ‭‬ ‭Exogenous‬ ‭indicators of whether someone is likely to‬ ‭‬ ‭Endogenous ( free chole – 30%; choesterol‬ ‭have a heart attack tests that have been‬ ‭ester – 70%)‬ ‭shown to be good indicators of whether‬ ‭‬ ‭Transported in the blood by HDL and LDL‬ ‭someone is likely to have a heart attack or‬ ‭‬ ‭Associated with development of coronary‬ ‭stroke caused by blockage of blood vessels‬ ‭heart disease, atherosclerosis, M.I.‬ ‭or hardening of the arteries (atherosclerosis)‬ ‭Phospholipid‬ ‭Includes:‬ ‭‬ ‭Most abundant lipid‬ ‭‬ ‭Total cholesterol‬ ‭‬ ‭Important component of the cell membrane‬ ‭‬ ‭High density lipoprotein cholesterol‬ ‭‬ ‭Forms:‬ ‭(HDL-C) — often called good cholesterol‬ ‭‬ ‭Lecithin (70%)‬ ‭‬ ‭Low density lipoprotein cholesterol‬ ‭○‬ ‭a.k.a. phosphatidylcholine‬ ‭(LDL-C) —often called bad cholesterol‬ ‭○‬ ‭lung surfactant‬ ‭‬ ‭Triglycerides‬ ‭‬ ‭Sphingomyelin ( 20%)‬ ‭‬ ‭Cephalin ( 10%)‬ ‭An extended profile may also include:‬ ‭‬ ‭Very low density lipoprotein cholesterol‬ ‭L/S ratio – measured to detect fetal lung maturity‬ ‭(VLDL-C)‬ ‭‬ ‭Specimen : amniotic fluid‬ ‭‬ ‭Non-HDL-C‬ ‭‬ ‭Ratio: >3.1:1 is good: 99% of the amount‬ ‭‬ ‭Adults:‬ ‭filtered‬ ‭○‬ ‭1.5 L/24 h‬ ‭○‬ ‭oliguria < 400 mL‬ ‭○‬ ‭anuria < 100 mL‬ ‭○‬ ‭polyuria > 3000 mL‬ ‭‬ ‭Children:‬ ‭○‬ ‭1.5 ml/Kg of b.w./1 hour‬ ‭ rine volume depends on how much you drink and‬ U ‭sweat. In health it is closely matched to water‬ ‭balance by the hormone ADH or vasopressin, AVP.‬ ‭ e define abnormally low urine volume as a 24 hour‬ W ‭How do you know it’s broken?‬ ‭volume less than 400 mL. This is known as oliguria.‬ ‭‬ ‭Decreased urine production‬ ‭‬ ‭Clinical symptoms‬ ‭ patient is considered anuric when there is no or‬ A ‭‬ ‭Tests‬ ‭little urine, less than 100 mL/24 h.‬ ‭ here is no absolute definition for polyuria as some‬ T ‭people can drink an awful lot and match it with a‬ ‭high urine output. If a patient has a urine volume‬ ‭greater than 3 litres per day and is not drinking then‬ ‭this is polyuria.‬ I‭ shall review the tests in the left column today. The‬ ‭measurement of urine protein is important in certain‬ ‭conditions, e.g.diabetes. The detection of substances‬ ‭such as red cells or glucose could be an early‬ ‭indicator of renal damage.‬ ‭Where can it break?‬ ‭‬ ‭Pre-renal‬ ‭‬ ‭Renal (intrarenal)‬ ‭‬ ‭Post-renal (obstruction)‬ ‭Causes of kidney functional disorders‬ ‭‬ ‭Pre-renal e.g. decreased intravascular‬ ‭volume‬ ‭‬ ‭Renal e.g. acute tubular necrosis‬ ‭‬ ‭Postrenal e.g. urethral obstruction‬ ‭Oliguria is a significant finding in a patient. An‬ ‭example is provided by Case 3 in the Chem Path‬ ‭tutorials. The traditional classification of causes is‬ ‭into prerenal, renal and postrenal. Usually the cause‬ ‭of the oliguria is obvious and can be appropriately‬ ‭managed.‬ ‭Tests of renal function‬ ‭‬ ‭glomerular filtration rate=GFR‬ ‭‬ ‭plasma creatinine= Pcr‬ ‭‬ ‭plasma urea-Purea‬ ‭‬ ‭urine volume= V‬ ‭‬ ‭urine urea- Uurea‬ ‭‬ ‭urine protein‬ ‭‬ ‭urine glucose‬ ‭‬ ‭hematuria‬ ‭‬ ‭osmolality‬ ‭I shall review the tests in the left column today. The‬ ‭measurement of urine protein is important in certain‬ ‭conditions, e.g.diabetes. The detection of substances‬ ‭such as red cells or glucose could be an early‬ ‭indicator of renal damage.‬ ‭ enal Function Tests-‬ R ‭Urine volumes‬ ‭Plasma urea (BUN)‬ ‭‬ ‭= BUN (blood urea nitrogen)‬ ‭‬ ‭Urea: product of protein catabolism‬ ‭‬ ‭Synthesized by liver, majority excreted by‬ ‭kidney, partially reabsorbed in tubules‬ ‭‬ ‭Plasma concentration increases with‬ ‭decreased GFR‬ ‭Urea is easily measured. It has a wide reference‬ ‭range and the value increases after a meal.‬ ‭Its concentration is increased in many different‬ ‭conditions which makes it sensitive to the presence of‬ ‭disease but a non-specific test.‬ ‭Glomerular filtration rate‬ ‭‬ ‭Glomerular filtration= major physiologic‬ ‭responsibility of kidney, GFR used as index‬ ‭of overall excretory function‬ ‭‬ ‭Methods:‬ ‭○‬ ‭clearence of inulin, creatinine,‬ ‭EDTA and DTPA (=both derivates‬ ‭of acetic acid), cystatin C‬ ‭○‬ ‭GFR= Ux x V (V=volum of urine/‬ ‭1 minute or 1 second)‬ ‭P x x= clearence of substance‬ ‭used‬ ‭Urea is easily measured. It has a wide reference‬ ‭range and the value increases after a meal.‬ ‭Its concentration is increased in many different‬ ‭conditions which makes it sensitive to the presence of‬ ‭disease but a non-specific test.‬ ‭‬ C ‭ reatine: main storage compound of high‬ ‭energy phosphate needed for muscle‬ ‭metabolism.‬ ‭‬ ‭Creatinine: anhydride of creatine!‬ I‭ n most circumstances the measurement of plasma‬ ‭creatinine can provide a specific test of glomerular‬ ‭function.‬ ‭The reference range is wide. A body builder may‬ ‭have a plasma creatinine at the top end and an old‬ ‭lady a value at the low end and this reflects muscle‬ ‭mass. Plasma creatinine should not be measured‬ ‭until 8 hours after a meal as there is some evidence‬ ‭that the concentration increases after meat ingestion.‬ ‭ lasma creatinine concentration increases when‬ P ‭GFR falls. The problem is that GFR has to fall quite‬ ‭a bit before plasma creatinine concentration reliably‬ ‭increases.‬ ‭ here are some important analytical interferences‬ T ‭which you should check with the laboratory. A‬ ‭patient with ketoacidosis, jaundice or infection might‬ ‭ nzymatic conductivity rate method for‬ E ‭have agents in the plasma which could invalidate the‬ ‭measuring urea‬ ‭measurement of creatinine.‬ ‭Overhead 1 follows‬ J‭ affe´ reaction for measuring creatinine, simple,‬ ‭but better is enzymatic method‬ ‭‬ ‭Creatinine + alkaline picrate solution‬ ‭‬ ‭Bright orange/red colored complex‬ ‭absorbs light at 485nm‬ ‭ n early test to detect renal damage, for instance a‬ A ‭ FR is not often measured in clinical practice. It‬ G ‭simple strip test for haematuria is important in‬ ‭requires a patient to come to hospital. Currently‬ ‭screening for heavy metal poisoning.‬ ‭people who are considering donating a kidney whilst‬ ‭they are alive have their GFR measured. Before‬ ‭ here is a clinical need to monitor a patient with‬ T ‭administering a drug with potentially toxic effects‬ ‭renal disease and this is achieved by serial plasma‬ ‭some patients will require a GFR measurement before‬ ‭measurements.‬ ‭the chemotherapy. This enables the oncologist to‬ ‭We need to know when to start dialysis in renal‬ ‭calculate the exact dose of drug after estimating its‬ ‭failure and laboratory tests assist the clinical‬ ‭elimination rate.‬ ‭decision making.‬ ‭There are about a million nephrons in each kidney‬ ‭ FR used to be measured by calculating the‬ G ‭and this represents a considerable functional reserve.‬ ‭clearance of inulin. Nowadays radioactive‬ ‭In renal disease about half the nephrons have to lose‬ ‭substances are used, either technetium labelled‬ ‭their functioning before the abnormality can be‬ ‭diethylenediaminetetra acetic acid DTPA or‬ ‭detected by conventional laboratory tests.‬ ‭51-chromium labelled EDTA ethylenediaminetetra‬ ‭acetic acid.‬ ‭Urea in patients with kidney diseases‬ ‭‬ ‭Useful test but must be interpreted with‬ ‭Analytical methods (Cr)‬ ‭great care, urea plasma level is more than‬ ‭‬ ‭Normal range Pcr‬ ‭creatinine dependent on protein intake‬ ‭○‬ ‭Male 0.6-1.2 mg/dL,‬ ‭‬ ‭Most useful when considered along with‬ ‭○‬ ‭Female 0.5-1.0 mg/dL‬ ‭creatinine‬ ‭‬ ‭High in high protein intake, low in severe‬ ‭liver dysfunction‬ ‭Plasma creatinine and renal functions‬ ‭‬ X ‭ -linked recessive disease‬ ‭‬ ‭Lack of HPRT causes a build-up of uric acid‬ ‭in all body fluids, and leads to symptoms‬ ‭such as severe gout, poor muscle control,‬ ‭and moderate retardation, which appear in‬ ‭the first year of life.‬ ‭Osmolality of urine‬ ‭‬ ‭Measures urine concentrating ability‬ ‭‬ ‭Depends on # of particles, not size or charge‬ ‭‬ ‭Largely due to ADH (antidiuretic hormone)‬ ‭‬ ‭Can reach maximum of 1200 mOsm/L‬ ‭‬ ‭Normal range:‬ ‭300-900mOsm/L, plasma‬ ‭285+10‬ ‭‬ ‭Prior to collection, fluid intake restricted,‬ ‭first void submitted for evaluation‬ ‭Urine dipsticks‬ ‭‬ ‭Strip impregnated with reagents for the‬ ‭substances in question within a urine sample‬ ‭‬ ‭Substance level can be altered in the setting‬ ‭of pathology within the urinary tract‬ ‭‬ ‭Measured substances:‬ ‭‬ ‭Modern dipsticks with multiplied zones:‬ ‭○‬ ‭Protein, hemoglobin, glucose,‬ ‭urobilinogen, nitrite, leukocytes,‬ ‭specific gravity, and pH‬ ‭‬ ‭Should be a tool everywhere on the level of‬ ‭primary care!!!‬ ‭Lesch Nyhan Syndrome‬ ‭‬ ‭rare, inherited disorder caused by a‬ ‭deficiency of the enzyme‬ ‭hypoxanthine-guanine‬ ‭phosphoribosyltransferase (HPRT)‬ ‭CLINICAL CHEMISTRY‬ ‭LIVER FUNCTION TESTS‬ ‭BY: DR. CATHERINE CABABA‬ ‭Anatomy of the Liver‬ (‭ fibrinogen), II (prothrombin), V, VII, IX,‬ ‭XSynthesis of plasma proteins, such as‬ ‭albumin and globulin, and coagulation‬ ‭factors I (fibrinogen), II (prothrombin), V,‬ ‭VII, IX, X and XI,‬ ‭ ‬ ‭Blood detoxification and purification‬ ‭Carbohydrate Metabolism‬ ‭‬ ‭Through the process of glycogenesis,‬ ‭glucose, fructose, and galactose are‬ ‭converted to glycogen and stored in the‬ ‭liver.‬ ‭‬ ‭Through the process of glycogenolysis, the‬ ‭liver breaks down stored glycogen to‬ ‭maintain blood glucose levels when there is‬ ‭a decrease in carbohydrate intake.‬ ‭‬ ‭Through the process of gluconeogenesis, the‬ ‭‬ l‭argest internal organ in the body‬ ‭liver synthesizes glucose from proteins or‬ ‭‬ ‭weighs about 3 pounds‬ ‭fats to maintain blood glucose levels.‬ ‭‬ ‭Covered by Glisson's capsule‬ ‭‬ ‭divided into a large right lobe and a smaller‬ ‭Lipid Metabolism‬ ‭left lobe.‬ ‭‬ ‭Cholesterol synthesis‬ ‭‬ ‭hepatic lobules are the functioning units of‬ ‭‬ ‭Lipogenesis, the production of triglycerides‬ ‭the liver‬ ‭(fats).‬ ‭‬ ‭Each of the approximately 1 million lobules‬ ‭consists of a hexagonal row of hepatic cells‬ ‭Other functions‬ ‭called hepatocytes‬ ‭‬ ‭immunological effects- the‬ ‭‬ ‭Between each row of hepatocytes are small‬ ‭reticuloendothelial system of the liver‬ ‭cavities called sinusoids‬ ‭contains many immunologically active cells,‬ ‭‬ ‭Each sinusoid is lined with Kupffer cells,‬ ‭acting as a 'sieve' for antigens carried to it‬ ‭phagocytic cells that remove amino acids,‬ ‭via the portal system‬ ‭nutrients, sugar, old red blood cells, bacteria‬ ‭‬ ‭Synthesis of angiotensinogenSynthesis of‬ ‭and debris from the blood‬ ‭angiotensinogen, a hormone that is‬ ‭responsible for raising the blood‬ ‭Physiology of the Liver‬ ‭pressureSynthesis of angiotensinogen, a‬ ‭‬ ‭Bile production and excretion‬ ‭hormone that is responsible for raising the‬ ‭‬ ‭Excretion of bilirubin, cholesterol,‬ ‭blood pressure when activated by‬ ‭hormones, and drugs‬ ‭reninSynthesis of angiotensinogen, a‬ ‭‬ ‭Metabolism of fats, proteins, and‬ ‭hormone that is responsible for raising the‬ ‭carbohydrates‬ ‭blood pressure when activated by renin, a‬ ‭‬ ‭Enzyme activation‬ ‭kidney enzyme that is released when the‬ ‭‬ ‭Storage of glycogen, vitamins, and minerals‬ ‭juxtaglomerular apparatusSynthesis of‬ ‭‬ ‭Synthesis of plasma proteins, such as‬ ‭angiotensinogen, a hormone that is‬ ‭albumin and globulin, and coagulation‬ ‭responsible for raising the blood pressure‬ ‭factorsSynthesis of plasma proteins, such as‬ ‭when activated by renin, a kidney enzyme‬ ‭albumin and globulin, and coagulation‬ ‭that is released when the juxtaglomerular‬ ‭factors ISynthesis of plasma proteins, such‬ ‭apparatus senses low blood pressure‬ ‭as albumin and globulin, and coagulation‬ ‭factors I (fibrinogen), IISynthesis of plasma‬ ‭Breakdown‬ ‭proteins, such as albumin and globulin, and‬ ‭‬ ‭breakdown of insulinbreakdown of insulin‬ ‭coagulation factors I (fibrinogen), II‬ ‭and other hormones‬ ‭(prothrombin), VSynthesis of plasma‬ ‭‬ ‭breakdown of hemoglobinbreakdown of‬ ‭proteins, such as albumin and globulin, and‬ ‭hemoglobin, creating metabolitesbreakdown‬ ‭coagulation factors I (fibrinogen), II‬ ‭of hemoglobin, creating metabolites that are‬ ‭(prothrombin), V, VIISynthesis of plasma‬ ‭added to bilebreakdown of hemoglobin,‬ ‭proteins, such as albumin and globulin, and‬ ‭creating metabolites that are added to bile as‬ ‭coagulation factors I (fibrinogen), II‬ ‭pigment (bilirubinbreakdown of‬ ‭(prothrombin), V, VII, IXSynthesis of‬ ‭hemoglobin, creating metabolites that are‬ ‭plasma proteins, such as albumin and‬ ‭added to bile as pigment (bilirubin and‬ ‭globulin, and coagulation factors I‬ ‭biliverdin)‬ ‭‬ b‭ reakdown or modification of‬ ‭Direct-reacting Bilirubuin (conjugated)‬ ‭toxicbreakdown or modification of toxic‬ ‭‬ ‭elevations typically result from obstruction‬ ‭substances (eg. methylation) and most‬ ‭either within the liver (intrahepatic) or a‬ ‭medicinal products in a process called drug‬ ‭source outside the liver‬ ‭metabolism‬ ‭‬ ‭e.g. gallstones or a tumor blocking the bile‬ ‭‬ ‭conversion of ammoniaconversion of‬ ‭ducts‬ ‭ammonia to urea‬ ‭Indirect-reacting Bilirubin (unconjugated)‬ ‭Bilirubin‬ ‭‬ ‭elevated levels are usually caused by liver‬ ‭‬ ‭bile pigment produced by the breakdown of‬ ‭cell dysfunction‬ ‭haem and reduction of biliverdin‬ ‭‬ ‭e.g. hepatitis‬ ‭‬ ‭Unconjugated bilirubin is insoluble in‬ ‭plasma unless bound to protein, mainly‬ ‭albumin.‬ ‭‬ S ‭ alicylates, sulphonamides, non-esterified‬ ‭fatty acids and reduced pH levels result in‬ ‭decreased protein-binding of unconjugated‬ ‭bilirubin.‬ ‭‬ ‭Normally, 95% of the circulating bilirubin is‬ ‭unconjugated.‬ ‭‬ ‭The bilirubin-albumin complex is‬ ‭dissociated by receptors on hepatocytes.‬ ‭‬ ‭The albumin remains in the plasma.‬ ‭‬ ‭The bilirubin is taken into the hepatocyte‬ ‭and conjugated by the enzyme bilirubin‬ ‭ ongenital & Acquired Disorders of Bilirubin‬ C ‭UDP-glucuronyl transferase to form‬ ‭Metabolism‬ ‭bilirubin diglucuronide. It is this‬ ‭1.‬ ‭Gilbert’s syndrome (Bilirubin Transpot‬ ‭water-soluble glucuronate derivative which‬ ‭Deficit)‬ ‭is excreted into the biliary system.‬ ‭- Impaired Cellular Uptake of Bilirubin‬ ‭‬ ‭In the gut, principally the colon, bilirubin‬ ‭glucoronides are degraded by bacteria and‬ ‭2.‬ C ‭ rigler Najjar Syndrome (Conjugation‬ ‭converted into a mixture of compounds,‬ ‭Deficit)‬ ‭known as urobilinogen or stercobilinogen;‬ ‭- No conjugation of Bilirubin‬ ‭these are water soluble.‬ ‭- Deficiency of UDP-GT‬ ‭‬ ‭Most of the urobilinogen is excreted in the‬ ‭- Leads to kernicterus – deposition of‬ ‭faeces where it is oxidised to urobilin which‬ ‭bilirubin in the brain‬ ‭is brown.‬ ‭‬ ‭Some is reabsorbed into the liver where it is‬ ‭re-excreted. When the amount of‬ ‭3.‬ D ‭ ubin-Johnson syndrome (Excretion‬ ‭urobilinogen is increased, some passes into‬ ‭Deficits)‬ ‭the systemic circulation and is excreted in‬ ‭- defective excretion of bilirubin by the liver‬ ‭the urine‬ ‭cells‬ ‭ ypes of Bilirubin‬ T ‭Liver Function Tests‬ ‭“Conjugated" or "Direct bilirubin“‬ ‭1.‬ ‭Alanine transaminase (ALT)‬ ‭‬ ‭Water Soluble – Yes(bound to glucuronic‬ ‭‬ ‭Serum Glutamic Pyruvate Transaminase‬ ‭acid)‬ ‭(SGPT) or Alanine aminotransferase‬ ‭‬ ‭Reacts quickly when diazo reagent is added‬ ‭(ALAT)‬ ‭to the blood specimen to produce‬ ‭‬ ‭present in hepatocytes (liver cells) When a‬ ‭azobilirubin "Direct bilirubin"‬

Use Quizgecko on...
Browser
Browser